NCT06739720 - RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Fatigue Syndrome (CFS)Post-COVID ME/CFS

Interventions

DRUG

LingZhi capsule

Lingzhi-containg capsules (CP003) is a Chinese Medicine nutritional supplement manufactured by Chinese Pharm CO LTD containing: wild red ganoderma extract, ganoderma spore powder (99.9% broken wall), β-nicotinamide mononucleotide (NMN), wild yellow ganoderma extract, wild green ganoderma extract, wild purple ganoderma extract, wild white ganoderma extract, wild black sesame extract

Trial Locations (1)

Unknown

Specialist Clinical Centre for Teaching and Research, School of Chinese Medicine, The University of Hong Kong, Hong Kong

All Listed Sponsors

collaborator

Innovation and Technology Commission, Hong Kong

OTHER

lead

The University of Hong Kong

OTHER